Related Experiment Video
Updated: May 10, 2026
08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Epigenetics: the fine-tuner in inflammatory bowel disease?
1Department of Pathobiology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. styliae@ccf.org
Current Opinion in Gastroenterology
|June 8, 2013
Summary
Epigenetic modifications are key to understanding complex diseases like cancer and inflammatory bowel disease (IBD). Targeting these epigenetic factors shows promise for developing new therapies for IBD and other conditions.
Area of Science:
- Epigenetics and its role in complex diseases.
- Focus on inflammatory bowel disease (IBD).
Background:
- Epigenetic studies are revolutionizing the understanding of cancer, autoimmune, and inflammatory diseases.
- Emerging themes in epigenetics are crucial for disease pathogenesis.
Purpose of the Study:
- Review major recent advances in epigenetics.
- Highlight emerging themes relevant to cancer, autoimmune, and inflammatory diseases, particularly IBD.
Main Methods:
- Review of current literature on epigenetics in disease.
- Focus on histone modifications, DNA methylation, metabolic pathways, epigenetic heritability, and chromatin readers.
- Discussion of epigenetic modifications in IBD pathogenesis.
Main Results:
- Epigenetic factors are increasingly understood in disease mechanisms.
- DNA methylation and histone modifications play significant roles.
- Epigenetic changes fine-tune gene expression in intestinal disorders like IBD.
- Chromatin readers are emerging as potential therapeutic targets.
Conclusions:
- Targeting epigenetic factors demonstrates efficacy in cancer and inflammatory diseases.
- Future research will uncover new epigenetic targets and mechanisms.
- Advancements in selective epigenetic therapy for IBD and complex diseases are anticipated.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:17Irritable Bowel Syndrome I: Introduction
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...